Phase 2 clinical trial of rapamycin-resistant donor CD4+ Th2/Th1 (T-Rapa) cells after low-intensity allogeneic hematopoietic cell transplantation

Daniel H. Fowler, Miriam E. Mossoba, Seth M. Steinberg, David C. Halverson, David Stroncek, Hahn M. Khuu, Frances T. Hakim, Luciano Castiello, Marianna Sabatino, Susan F. Leitman, Jacopo Mariotti, Juan C. Gea-Banacloche, Claude Sportes, Nancy M. Hardy, Dennis D. Hickstein, Steven Z. Pavletic, Scott Rowley, Andre Goy, Michele Donato, Robert KorngoldAndrew Pecora, Bruce L. Levine, Carl H. June, Ronald E. Gress, Michael R. Bishop

Research output: Contribution to journalArticlepeer-review

23 Scopus citations

Fingerprint Dive into the research topics of 'Phase 2 clinical trial of rapamycin-resistant donor CD4<sup>+</sup> Th2/Th1 (T-Rapa) cells after low-intensity allogeneic hematopoietic cell transplantation'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds